Emerging Mental Health Treatments in Trials
The mental health clinical trial landscape in the UK is rapidly evolving. Psychedelic-assisted therapy โ using psilocybin for depression and MDMA for PTSD โ has shown remarkable results in early trials and is advancing to larger studies. Neuromodulation techniques like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) offer non-pharmaceutical options for treatment-resistant depression. Digital therapeutics, including app-based CBT and AI-guided therapy, are being tested as scalable interventions.
Accessing Mental Health Trials Through the NHS
Many mental health trials in the UK are conducted through NHS mental health trusts, IAPT services, and specialist psychiatric centres. Your GP, psychiatrist, or community mental health team can refer you. Some trials also accept self-referrals. The National Institute for Health and Care Research (NIHR) maintains a registry of all NHS mental health trials currently recruiting.
Treatment-Resistant Conditions
A significant proportion of mental health trials focus on patients who have not responded to standard treatments. Treatment-resistant depression (TRD) is a particularly active area, with trials testing ketamine, psilocybin, deep brain stimulation, and novel glutamate modulators. If you have tried two or more treatments without adequate response, you may be eligible for these specialised trials.
๐ Conditions
โ๏ธ Comparisons
๐ฐ Related Articles
- Mental Health Clinical Trials UK 2026 Guide โ Guide to mental health trial types including psychedelics and digital therapeutics
- Depression Clinical Trials UK โ From SSRIs to psilocybin โ what is being tested for depression
- Anxiety Clinical Trials UK โ Novel approaches to anxiety treatment in clinical research
Frequently Asked Questions
Find Your Clinical Trial
Search thousands of actively recruiting trials across the UK โ free, instant, no registration.
Search Trials Now Read the Guide